Understanding the metabolic dependencies of cancer cells can inform therapeutic strategies. Drugs that target specific metabolic pathways are being developed to exploit the metabolic vulnerabilities of tumor cells. For instance, glutaminase inhibitors are designed to disrupt glutamine metabolism, which is critical for the growth of certain cancers. Additionally, metabolic profiling can help predict patient response to therapies and guide personalized treatment plans.
